Oppenheimer analyst Hartaj Singh downgraded Astria Therapeutics (NASDAQ: ATXS) from Outperform to Perform.The analyst comments "This morning ATXS ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE